Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CNSP
#4004
CNS Pharmaceuticals, Inc. Common Stock
3.1
6
+4.29%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+4.29%
Monthly Change
-48.11%
6 month change
-49.76%
Cambio anual
+35.62%
Cierres anteriores
3.0
3
Open
3.1
7
Bid
Ask
Low
3.0
9
High
3.1
7
Volumen
4
Markets
Acciones
Atención Sanitaria
CNSP
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.6
-1.6
-1.17
-11.08
-1.71
-1.11
Return on equity %
0.68
-2.12
-1.88
4.25
-2.41
-1.41
Return on invested capital %
6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
—
Gross margin %
100
—
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
24.41
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
0
0
Solvency ratios
Debt to assets ratio
0.06
0.09
0.07
—
—
—
Debt to equity ratio
0.07
0.12
0.11
—
—
—
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.08
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-204.35
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
18.94 K
—
—
—
Cash per share
—
—
221.53 K
4 369.53
202.85
310.69
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
390.8
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Working capital per share
—
—
168.41 K
-36.17 K
192.58
292.07
Book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Noticias
CNS Pharmaceuticals appoints three new executives to leadership team
El nuevo director ejecutivo de CNS Pharmaceuticals describe una reestructuración estratégica
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security nombra a Michelle Ragusa-McBain como jefa de canal
Corero Network Security nombra a Michelle Ragusa-McBain como jefa de canal
Corero Network Security mejora su plataforma de protección contra DDoS
Corero Network Security anuncia mejoras en su plataforma de protección DDoS
Corero Network Security reports DDoS protection platform enhancements
Las acciones de CNS Pharmaceuticals caen tras la dimisión de su director ejecutivo
Acciones de CNS Pharmaceuticals caen tras renuncia del CEO
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals nombra a Rami Levin como nuevo director ejecutivo, reemplazando a Climaco